Regulus Therapeutics Inc (RGLS)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.18M | -7.56M | -6.93M | -7.37M | -7.32M | -8.13M | -8.3M | -8.83M |
| Pre Tax Income | -7.26M | -7.55M | -6.8M | -7.14M | -7.01M | -7.82M | -8.06M | -8.47M |
| Net Income | -7.26M | -7.55M | -6.8M | -7.14M | -7.01M | -7.82M | -8.06M | -8.47M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -7.18M | -7.56M | -6.93M | -7.37M | -7.32M | -8.13M | -8.3M | -8.83M |
| EBITDA | -7.14M | -7.53M | -6.9M | -7.32M | -7.27M | -8.07M | -8.22M | -8.75M |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.19M | 72k | 72k | 6.83M | 10.01M | 0 | 0 | 0 |
| Operating Income | -81.5M | -70.13M | -46.76M | -16.83M | -14.16M | -27.82M | -28.24M | -31.11M |
| Pre Tax Income | -81.84M | -72.1M | -48.65M | -18.59M | -15.73M | -27.81M | -28.32M | -30.04M |
| Net Income | -81.84M | -71.91M | -48.71M | -18.59M | -15.73M | -27.81M | -28.32M | -30.04M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -1.546 | -0.692 | -5.524 | -0.885 | -0.233 | -0.191 | -1.682 | -1.185 |
| EBIT | -81.5M | -70.13M | -46.76M | -16.83M | -14.16M | -27.82M | -28.24M | -31.11M |
| EBITDA | -79.23M | -67.61M | -44.5M | -15.9M | -13.69M | -27.36M | -28.12M | -30.88M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
